Observational studyMedicine2025
Efficacy of traditional Chinese medicine prescription in treatment of COVID-19: A prospective cohort study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe purpose of this study was to estimate the efficacy of traditional Chinese medicine (TCM) prescription in the treatment of coronavirus disease 2019 (COVID-19).
methodsA multicenter prospective cohort study at 7 hospitals was conducted. The COVID-19 inpatients were divided into 2 groups. The control group received conventional treatment, and the TCM group received conventional treatment in combination with TCM prescription (Huashi Xuanfei decoction, Jiedu Xiefei decoction and Jianpi Bufei decoction). The 24 clinical symptoms of each patient were surveyed during 7 periods. The partial least squares discriminant analysis algorithm and Mann-Whitney U test were applied to systematical analyzing the differences in clinical symptoms between the 2 groups.
resultsA total of 38 and 77 cases were included for data analysis in the control and TCM groups, respectively. There were significant differences in scores of fever between the control and TCM groups on days 2 to 4 (1.00 vs 0.29, P = .003) and days 6 to 8 (0.53 vs 0.07, P = .024). The scores of poor appetite had significant differences between the control and TCM groups on days 0 to 1 (0.08 vs 0.51, P = .000), days 2 to 4 (0.05 vs 0.39, P = .001), days 20 to 22 (0.24 vs 0.05, P = .004) and days 27 to 29 (0.14 vs 0.03, P = .044). The scores of expectoration had significant differences on days 0 to 1 (0.32 vs 0.83, P = .000) and days 2 to 4 (0.24 vs 0.59, P = .001).
conclusionThe superiority of TCM prescription in improving symptoms of fever, poor appetite, and expectoration was demonstrated. The treatment regimen of using conventional treatment in combination with TCM prescription can significantly improve the clinical symptoms of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.